Apr. 2 at 3:53 AM
$PLX @milt0n I asked chatgpt a bunch of questions based on Milt's below post about these countries which are more likely to approve the new E4W dosing for reimbursement the quickest (possibly within 3–6 months of Chiesi’s national submissions) : Germany, Italy, Netherlands, Belgium, Sweden. Here is the approx people with Fabry in these countries:
700 to 2,000 in Germany, 500 to 1,500 in Italy, 150 to 450 Netherlands, 120 to 300 in Belgium, 50 to 60 in Sweden
That is around 1520 on the low end of these countries and around 4310 on the high end.
I took the low number (1520) and took 25% of it which is 380.
Then I multiplied 380 by about 100K (USD) per patient per year which is 38 million USD. It is probably higher than 100K (USD) per year, but I only asked chatgpt about the price in Germany and it said that it was equivalent to 115K (USD) per year. So I averaged down a bit.
